 Hemolytic anemia use omeprazole Omeprazole first drug final step acid secretory process parietal cell effective treatment peptic ulcer disease reflux esophagitis Zollinger-Ellison syndrome clinical experience omeprazole limited many studies short-term safety drug first case serious short-term adverse reaction use omeprazole hemolytic anemia patient weakness lethargy shortness breath days therapy omeprazole weeks initiation therapy hematocrit positive direct Coombs antiglobulin test elevated indirect bilirubin omeprazole hemoglobin hematocrit normal mechanism omeprazole patient hemolytic anemia uncertain physicians possible adverse effect